Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
|
CN |
|
F
|
Fuxing China Group Ltd
SGX:AWK
|
CN |
|
HomeStreet Inc
NASDAQ:HMST
|
US |
|
Mineralbrunnen Ueberkingen-Teinach GmbH & Co KgaA
F:MUT
|
DE |
|
Centrotherm International AG
F:CTNK
|
DE |
|
Aperam SA
AEX:APAM
|
LU |
|
N
|
New Focus Auto Tech Holdings Ltd
HKEX:360
|
CN |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
B
|
Budi Starch & Sweetener Tbk PT
IDX:BUDI
|
ID |
|
CDA SA
F:6LC
|
PL |
|
S
|
Sun Life Financial Inc
NYSE:SLF
|
CA |
|
Ekinops SA
PAR:EKI
|
FR |
|
Green Plains Inc
NASDAQ:GPRE
|
US |
Wall Street
Price Targets
Price Targets Summary
Zhejiang Huahai Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Zhejiang Huahai Pharmaceutical Co Ltd
is 18.02 CNY
with a low forecast of 13.13 CNY and a high forecast of 23.1 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Huahai Pharmaceutical Co Ltd's stock price target?
Price Target
18.02
CNY
According to Wall Street analysts, the average 1-year price target for
Zhejiang Huahai Pharmaceutical Co Ltd
is 18.02 CNY
with a low forecast of 13.13 CNY and a high forecast of 23.1 CNY.
What is Zhejiang Huahai Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Zhejiang Huahai Pharmaceutical Co Ltd's revenue is
14%.
The projected
CAGR
for the next 4 years is
6%.
What is Zhejiang Huahai Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Zhejiang Huahai Pharmaceutical Co Ltd's operating income is
13%.
The projected
CAGR
for the next 4 years is
15%.
What is Zhejiang Huahai Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Zhejiang Huahai Pharmaceutical Co Ltd's net income is
13%.
The projected
CAGR
for the next 3 years is
7%.
